Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 27,527,415 shares, a drop of 15.2% from the February 12th total of 32,453,225 shares. Based on an average daily trading volume, of 3,871,657 shares, the days-to-cover ratio is currently 7.1 days. Approximately 30.4% of the company’s stock are short sold. Approximately 30.4% of the company’s stock are short sold. Based on an average daily trading volume, of 3,871,657 shares, the days-to-cover ratio is currently 7.1 days.

Wall Street Analyst Weigh In

A number of brokerages have commented on ACHC. Royal Bank Of Canada increased their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, February 26th. Mizuho dropped their target price on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft reduced their price target on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Barclays boosted their price target on Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Tuesday, March 3rd. Finally, TD Cowen upped their price objective on Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Price Performance

Shares of ACHC opened at $23.52 on Monday. The company’s 50-day moving average is $16.80 and its 200-day moving average is $18.73. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.55. The firm has a market capitalization of $2.17 billion, a PE ratio of -1.93, a PEG ratio of 7.95 and a beta of 0.73. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $31.04.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Equities analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.

More Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia added Daniel Cancelmi to its Board of Directors, a governance move that can be viewed positively as expanding board expertise and oversight. Article Title
• Neutral Sentiment: Reported short-interest data shows zero shares and days-to-cover of 0.0 — the release appears to contain anomalous or missing data (NaN/0) and therefore provides no clear signal about bearish positioning.
• Negative Sentiment: Zacks Research cut multiple near-term and multi-year EPS estimates and keeps a “Hold” rating. Key changes include Q2 2026 EPS cut to $0.49 (from $0.66), FY2026 to $1.48 (from $1.85), and FY2027 to $1.55 (from $1.96), plus several quarter-by-quarter reductions across 2026–2027. These downward revisions lower investor expectations and are the main reason for today’s downward pressure on the stock.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in the company. Allworth Financial LP grew its holdings in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the period. Wells Fargo & Company MN grew its stake in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares in the last quarter. Bayforest Capital Ltd bought a new position in Acadia Healthcare during the fourth quarter worth about $52,000. Finally, Hantz Financial Services Inc. raised its stake in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.